US-guided Percutaneous Electrolysis (EPE®) in Shoulder Pain
Shoulder Pain
About this trial
This is an interventional treatment trial for Shoulder Pain focused on measuring Subacromial pain syndrome, Eccentric exercise, Pressure pain, US-guided percutaneous electrolysis
Eligibility Criteria
Inclusion Criteria:
- unilateral shoulder complaints with duration of at least 3 months;
- an intensity of at least 4 on an 11-point numerical pain rating scale (NPRS) during arm elevation;
- a positive painful arc test during abduction
- at least one positive of the following tests: Hawkins-Kennedy test, Neer's sig, empty can test, drop arm or lift-off test
Exclusion Criteria:
- bilateral shoulder symptoms
- younger than 18 or older than 65 years
- history of shoulder fractures or dislocation
- cervical radiculopathy
- previous interventions with steroid injections
- fibromyalgia syndrome
- previous history of shoulder or neck surgery
- any type of intervention for the neck-shoulder area during the previous year
Sites / Locations
- Cesar Fernandez-de-Las-Peñas
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
US-guided percutaneous electrolysis
Eccentric exercise
Patients will receive one weekly session for 5 weeks including best-evidence manual therapy and an eccentric loading exercise program for the shoulder musculature, particularly the supraspinatus and infraspinatus muscles. The exercise program will be asked to be performed on an individual basis twice every day. The therapeutic protocol will be applied for 5 weeks. In addition, they will receive one session of US-guided percutaneous electrolysis. This intervention consists of the application of a galvanic electrical current with an acupuncture needle in the soft tissue, in this case the supraspinatus tendon.
Patients will receive one weekly session for 5 weeks including best-evidence manual therapy and an eccentric loading exercise program for the shoulder musculature, particularly the supraspinatus and infraspinatus muscles. The exercise program will be asked to be performed on an individual basis twice every day. The therapeutic protocol will be applied for 5 weeks.